Navigation Links
Meyskens honored with AACR-Prevent Cancer Foundation award
Date:10/24/2008

ers in the past decade considered the many challenges associated with the identification and development of markers as predictors of preventive effectiveness.

Currently, Meyskens is continuing the clinical development of the Bowman-Birk inhibitor, a soybean-derived serine protease inhibitor, being tested as a human cancer-preventive agent.

Meyskens received a Bachelor of Science degree from the University of San Francisco, and his Medical Degree from University of California, San Francisco Medical School. He completed his postdoctoral education at the Laboratory of Tumor Cell Biology, National Cancer Institute and the Medicine Branch, National Institutes of Health.

Meyskens has received numerous honors and awards for his scientific accomplishments, including the American Society of Preventive Oncology Distinguished Achievement Award and the University of California Irvine Lauds & Laurels Faculty Achievement Award. Meyskens has published more than 100 peer-reviewed laboratory and clinical manuscripts on the topic of cancer prevention and control.

An active member of the AACR since 1979, Meyskens has served in various capacities, including as editorial board member of Cancer Prevention Research, chairperson of the Biology and Genetics of Early Detection special conference, and as a member of several committees.

Meyskens will give an award lecture entitled, Optimizing Chemoprevention by Minimizing Risk-Benefit and Maximizing Risk-Reduction, on Monday, November 17, 2008, at 5:00 p.m., during the Seventh Annual International Conference on Frontiers in Cancer Prevention Research. This foremost meeting on cancer prevention research will be held November 16 - 19, 2008, at the Gaylord National Resort, Washington, DC.


'/>"/>

Contact: Megan J. Davies
megan.davies@aacr.org
267-646-0612
American Association for Cancer Research
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. 8 National Medals of Science awardees to be honored at gala, then the White House
2. Sir David Lane honored with Royal Gold Medal by Royal Society of Edinburgh
3. Inaugural Kavli laureates honored in Oslo ceremony
4. Leader of Human Genome Project honored with the Inamori Ethics Prize
5. Sen. Byron Dorgan to be honored
6. Springer editor honored with top environmental prize
7. Yales Anastas honored for leadership in founding of green chemistry
8. NJIT Provost Priscilla P. Nelson honored at National Academy of Engineering
9. Jeremy Jackson honored by Harvard Museum of Natural History
10. Rices West honored as one of Texas best researchers
11. UT Southwestern scientist honored among best in Texas research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 9 BIO-key International, Inc. (OTC ... biometric identification solutions, today announced that SC ... security publications, named BIO-key International the 2009 ... Control sub-category Biometrics. ,, (Logo: ... technology editor, SC Magazine, "Biometric providers have ...
(Date:12/15/2009)... 2009 Frost & Sullivan European Border Security ... Securite (Safran Group) for its innovative Automated ... company,s expertise in advanced biometric technology and ... products to end users. ,, (Logo: ... has been involved in delivering identification systems ...
(Date:12/15/2009)... just signed an agreement with the British Society for ... with the journal Biogerontology for an initial ... one member of the Biogerontology editorial board ... Springer will sponsor the society and provide society ... on www.springerlink.com . , Biogerontology offers ...
Breaking Biology News(10 mins):BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Ikaria 28R 29 Names New Chairman 14523 1Ikaria 28R 29 Names New Chairman 14523 2Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 1Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 2Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 3Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 4Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 5Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 6Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 7Jennerex Inc Receives EMEA Orphan Drug Designation for JX 594 for the Treatment of Hepatocellular Carcinoma 5557 1Jennerex Inc Receives EMEA Orphan Drug Designation for JX 594 for the Treatment of Hepatocellular Carcinoma 5557 2Jennerex Inc Receives EMEA Orphan Drug Designation for JX 594 for the Treatment of Hepatocellular Carcinoma 5557 3
... is a defensive, protective reaction. This ancestral and automatic ... potential predator. A new study published in Psychophysiology finds ... encountering a threat. The mere picture of an injured ... unpleasant images, the study's participants froze as their heart ...
... at Yale have identified a gene that regulates the ... according to a recent report in the journal Cell. ... zone of dead cells around an infection site that ... of Molecular, Cellular and Developmental Biology at Yale and ...
... new pan-genome , Ever since the genomics revolution ... numbers of genomes. Cataloging. Analyzing. Comparing. Public databases ... scientists at The Institute for Genomic Research (TIGR) ... the powerful tools of comparative genomics and mathematics, ...
Other Biology News:When in danger humans are similar to a deer in the headlights 2Researchers predict infinite genomes 2Researchers predict infinite genomes 3
(Date:12/16/2009)... -- Capitalizing on the continued strong ... active venture capital market, leaders from BioCrossroads, Eli ... Indiana University, Purdue University, the University of Notre ... today announced the establishment of the INext Fund, ... ,, Organized through BioCrossroads, Indiana,s initiative to grow, ...
(Date:12/16/2009)... DIEGO, Dec. 16 Sequenom, Inc. (Nasdaq: ... Dr. Kenneth Buechler and Mr. David Pendarvis to ... http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO ) ,, Kenneth F. Buechler, Ph.D., ... Biosite Incorporated. From 1988 to 1994, Dr. Buechler ... Biosite, Dr. Buechler was a senior research scientist ...
(Date:12/16/2009)... December 16 Eppendorf has initiated ... Verigene(R) SP systems for,infringement of European patent ... for the,identification and/or the quantification of a ... all imports of the respective products into ... are required to confiscate any,violating products. , ...
(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader in the ... of the cutting-edge science behind its lead oncology ... world rediscovered the Cyclin G1 gene ... and disease progression, and thus a prime target ... National Cancer Institute investigating the role of microRNAs ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... Sequential Profitable Quarter -- -- Conference Call ... BEIJING, March 31 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), ... results for the three months and twelve months ended December ... 2007 sales of $33.5 million, up 118% year-over-year ...
... 28 Eisai Co.,Ltd. and its U.S. subsidiary ... States District Court for the District of New,Jersey ... Eisai,s motion for a,preliminary injunction in its patent ... Pharmaceuticals (collectively,"Teva"), concerning Aricept(R) (generic name: donepezil hydrochloride,tablets)., ...
... N.J., March 28 Memory,Pharmaceuticals Corp. (Nasdaq: ... public accounting firm included an explanatory,paragraph in their ... recently filed Annual Report on Form 10-K for ... Company,s ability to continue as a going,concern. The ...
Other Biology Technology:Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 2Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 3Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 4Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 5Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 6Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 7Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 8Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals 2Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals 3Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification 2
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Component in MasterPure™ Purification Kits...
...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile...
Biology Products: